Contrasting Disease Landscapes in Israel and Somaliland
Health at the Crossroads: Contrasting Disease Landscapes in Israel and Somaliland
Israel and Somaliland present starkly contrasting public health landscapes. Israel, a high-income nation with advanced infrastructure, faces sporadic infectious disease outbreaks and a chronic disease burden typical of developed countries. Somaliland, by contrast, contends with endemic infectious diseases, fragile health systems, and rising chronic conditions, reflecting the challenges of a lower-income environment. Recent bilateral cooperation is reshaping Somaliland’s health profile, offering new opportunities for surveillance, care, and infrastructure improvement.
Infectious Disease Burden
Israel: Managed Risks in a Digitized System
Israel’s infectious disease threats are largely contained through robust surveillance and high routine vaccination coverage (~98% IPV). The country’s primary infectious concerns include seasonal respiratory viruses (influenza, RSV, COVID-19) and the periodic detection of vaccine-derived poliovirus in environmental samples. While no paralysis cases have been reported, these findings highlight immunity gaps in specific communities. Tuberculosis rates remain exceptionally low (2.8 per 100,000), and HIV diagnoses have declined by 22% in recent years, though stigma persists as a barrier to testing.
Somaliland: Endemic and Outbreak-Driven
Somaliland’s infectious disease profile is dominated by communicable diseases, with outbreaks of diphtheria, cholera, measles, and malaria posing significant threats. In early 2026, a diphtheria surge resulted in over 3,200 cases and 136 deaths. Measles remains a leading cause of child mortality, exacerbated by low and uneven vaccination coverage (20–42% DTP3). Waterborne diseases, particularly cholera, are recurrent due to fragile WASH infrastructure and climate-driven displacement. Tuberculosis and malaria are endemic, contributing substantially to morbidity and mortality.
Immunization and Public Health Infrastructure
Israel’s digital tracking system ensures high immunization rates, but the 2025 polio alert demonstrated that even advanced systems are vulnerable if sub-populations remain under-vaccinated. Somaliland faces an “immunity gap,” with 73% of recent diphtheria cases occurring in unvaccinated individuals. The establishment of the Somaliland Center for Disease Control (SL-CDC), supported by Israel, aims to modernize disease surveillance and response.
Impact of Conflict and Displacement
Both countries experience health challenges related to displacement. The Gaza conflict (2023–2025) in Israel led to outbreaks of scabies, hepatitis A, and multidrug-resistant infections among displaced populations. In Somaliland, internally displaced person (IDP) camps are hotspots for diarrheal and respiratory diseases.
Bilateral Cooperation and Strategic Initiatives
Following Israel’s formal recognition of Somaliland in December 2025, the two nations have launched a strategic health partnership. Israel is assisting Somaliland in establishing the Somaliland Center for Disease Control (SL-CDC) and providing expertise in water purification technologies to address waterborne illnesses. Programs such as “Save a Child’s Heart” are bridging gaps in pediatric cardiac care. Telemedicine platforms and medical training are being introduced to strengthen chronic disease management and specialist capacity in Somaliland.
Chronic Disease Profiles
Israel: Mature Non-Communicable Disease Landscape
Israel’s chronic disease burden is shaped by longevity (life expectancy: 83.4 years), with cancer and heart disease as leading causes of death. Non-communicable diseases (NCDs) account for 70–75% of mortality. Diabetes prevalence ranges from 10.1% in the general population to 18% among Arab Israelis, who also exhibit higher obesity rates. Mental health issues, particularly depression (33.9%) and chronic stress (67.9%), have surged following regional conflict.
Somaliland: Dual Burden and Rising NCDs
Somaliland is experiencing a “dual burden,” with chronic diseases rising alongside persistent infectious threats. NCDs now cause approximately 42% of deaths, with cardiovascular disease and diabetes as primary contributors. Hypertension is prevalent (41.1% in urban areas), often undiagnosed until severe complications arise. Urbanization and lifestyle shifts—sedentary jobs, processed diets—are driving chronic disease rates, while nomadic populations maintain lower risk due to traditional diets and higher physical activity.
Risk Factors and Lifestyle
Israel’s primary risk factors include smoking (17%), sedentary lifestyles, and longevity. Obesity is managed through nutrition programs led by HMOs. Somaliland’s risk profile is influenced by urbanization, lack of screening, and widespread use of khat, a stimulant linked to hypertension and cardiovascular strain. Obesity (14.6%) is increasingly seen as a “wealth disease” in urban households. Air quality issues differ: Israel faces ambient particulate pollution, while Somaliland’s respiratory burden is linked to indoor air pollution from traditional cooking methods.
Healthcare System Response
Israel’s healthcare system leverages big data for early detection and management of chronic conditions, shifting care to community clinics. Somaliland’s system, historically focused on acute infections, is expanding integrated care for hypertension and diabetes through pilot NCD clinics. Bilateral agreements are facilitating the introduction of telemedicine and specialist training, addressing critical gaps in chronic disease management.
In Israel, chronic diseases are managed conditions, allowing patients to live with them for decades. In Somaliland, late diagnosis often renders chronic diseases terminal events.
Israel and Somaliland exhibit contrasting health landscapes, with Israel managing infectious diseases through advanced surveillance and high vaccination rates while facing a mature chronic disease burden, whereas Somaliland struggles with endemic infectious diseases, low vaccination coverage, fragile health infrastructure, and a rising dual burden of chronic conditions, with recent bilateral cooperation enhancing Somaliland’s disease control and healthcare capacity.
